Mengxian Du
Harbin, 150081, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Chitosan-rapamycin carbon dots rejuvenate autologous Sca-1⁺ stem cells paracrine function for neuroprotection in normal tension glaucoma.
Journal: Stem cell research & therapy
Published: October 12, 2025
Revealing the role of regulatory microglial IRF7-NLRP3 interactions in optic nerve damage of normal-tension glaucoma based on single-cell RNA sequencing.
Journal: Frontiers in immunology
Published: September 08, 2025
Synergistic neuroprotective effects of the ROCK inhibitor Y27632 and atorvastatin in optineurin-E50K-mutant mice through inhibition of scleral fibroblast transdifferentiation.
Journal: Experimental eye research
Published: June 16, 2025
Microglia Drive Peripapillary Vascular Density Reduction in Normal Tension Glaucoma by Regulating the Rpl17/Stat5b/Apoa1 Axis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 30, 2025
Chitosan-Rapamycin Carbon Dots Alleviate Glaucomatous Retinal Injury by Inducing Autophagy to Promote M2 Microglial Polarization.
Journal: International journal of nanomedicine
Published: September 13, 2023
Proteomic analysis of aged and OPTN E50K retina in the development of normal tension glaucoma.
Journal: Human molecular genetics
Published: February 11, 2021
Neuroprotective effects of bone marrow Sca-1+ cells against age-related retinal degeneration in OPTN E50K mice.
Journal: Cell death & disease
Published: January 06, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026